LIVE

Serial Number

97187984

Owner

ROME Therapeutics, Inc.

Attorney

GLENN A GUNDERSEN

First Use Date

Apr 27, 2020

Filing Date

Dec 23, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ROME THERAPEUTICS Trademark

Serial Number: 97187984 • Registration: 8145678

ROME THERAPEUTICS is a trademark filed by ROME Therapeutics, Inc. on December 23, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

ROME Therapeutics, Inc. (5 trademarks)

201 Brookline Ave., Suite 1001
Boston, MA 02215

Entity Type: 03

Legal Representation

Attorney of Record

GLENN A GUNDERSEN

4 trademarks filed View all →

Correspondence Address

GLENN A GUNDERSEN DECHERT LLP

2929 ARCH STREET

CIRA CENTRE

PHILADELPHIA, PA 19104

United States

Trademark Details

Filing Date

December 23, 2021

Registration Date

February 17, 2026

First Use Anywhere

April 27, 2020

First Use in Commerce

April 27, 2020

Published for Opposition

December 10, 2024

Goods & Services

Pharmaceutical research and development in the field of cancer and autoimmune disease; pharmaceutical drug development and discovery services in the field of cancer and autoimmune disease; scientific research in the field of pharmaceuticals; providing scientific research information in the field of pharmaceuticals; none of the foregoing relating to gastrointestinal issues

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 17, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

Feb 17, 2026 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 26, 2026 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 26, 2026 CNPR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 22, 2026 EXRA

STATEMENT OF USE PROCESSING COMPLETE

Jan 21, 2026 SUPC

SOU EXTENSION 2 GRANTED

Jan 21, 2026 EX2G

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 31, 2025 EXRA

USE AMENDMENT FILED

Jul 30, 2025 IUAF

SOU EXTENSION 2 FILED

Jul 30, 2025 EXT2

TEAS STATEMENT OF USE RECEIVED

Jul 30, 2025 EISU

SOU EXTENSION 1 GRANTED

Jul 30, 2025 EX1G

SOU EXTENSION 1 FILED

Jul 30, 2025 EXT1

SOU TEAS EXTENSION RECEIVED

Jul 30, 2025 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 4, 2025 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 10, 2024 NPUB

PUBLISHED FOR OPPOSITION

Dec 10, 2024 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 4, 2024 NONP

EXPARTE APPEAL TERMINATED

Oct 15, 2024 EXPT

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 15, 2024 CNSA

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

Sep 6, 2024 GNS1

SUBSEQUENT FINAL EMAILED

Sep 6, 2024 GNSF

SUBSEQUENT FINAL REFUSAL WRITTEN

Sep 6, 2024 CFRC

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 15, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 15, 2024 CRFA

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Jul 15, 2024 ERSI

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

May 3, 2024 GNS3

LETTER OF SUSPENSION E-MAILED

May 3, 2024 GNSL

SUSPENSION LETTER WRITTEN

May 3, 2024 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

May 3, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 26, 2024 CRFA

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Jan 26, 2024 ERSI

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Dec 29, 2023 GNS3

LETTER OF SUSPENSION E-MAILED

Dec 29, 2023 GNSL

SUSPENSION LETTER WRITTEN

Dec 29, 2023 CNSL

EX PARTE APPEAL-INSTITUTED

Dec 6, 2023 EXPI

JURISDICTION RESTORED TO EXAMINING ATTORNEY

Dec 6, 2023 JURT

EXPARTE APPEAL RECEIVED AT TTAB

Dec 6, 2023 EXAF

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Dec 5, 2023 ERFR

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Aug 28, 2023 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Aug 28, 2023 XELR

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 25, 2023 TCCA

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Aug 25, 2023 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Aug 25, 2023 COAR

NOTIFICATION OF FINAL REFUSAL EMAILED

Jun 5, 2023 GNFN

FINAL REFUSAL E-MAILED

Jun 5, 2023 GNFR

FINAL REFUSAL WRITTEN

Jun 5, 2023 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 13, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 12, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 12, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 12, 2022 GNRN

NON-FINAL ACTION E-MAILED

Oct 12, 2022 GNRT

NON-FINAL ACTION WRITTEN

Oct 12, 2022 CNRT

ASSIGNED TO EXAMINER

Sep 27, 2022 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 30, 2021 NWOS

NEW APPLICATION ENTERED

Dec 27, 2021 NWAP

Related Trademarks

More from this Owner

ROME THERAPEUTICS

More in Same Class

21SHARES

ENGICAM

THREATMARK

Serial #79346511

B.TRAX

THINKING OUTSIDE THE GRID